Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
AI Revolutionises Early Detection of Liver Disease
November 2024
A new study reveals that AI can identify early-stage metabolic-associated steatotic liver disease using electronic health records.
Read more
19 Jan 2024
Low Screening and Treatment for Osteoporosis in Patients with Cirrhosis
Screening for osteoporosis is considerably lower in patients with cirrhosis compared with the general population, and less than 25% of those with low bone density are treated, according to a recent study. Read more.
8 Nov 2023
Does Testosterone Replacement Improve Steatotic Liver Disease?
Male hypogonadism is associated with visceral obesity and metabolic syndrome. The present study aims to compare the effects of testosterone treatment with a placebo in treating non-alcoholic fatty liver disease in older hypogonadal males.
7 Nov 2023
Novel Scoring Tool Predicts Alcoholic Relapse Following Liver Transplant
New data suggests that the risk of alcoholic relapse in patients with alcohol-related liver disease who underwent liver transplant may be more accurately determined with the help of a new scoring system.
13 Oct 2023
Waitlist Outcomes Improved by Living Donor Liver Transplantation
Waitlist outcomes are improved by living donor liver transplantation for high-risk patients with cirrhosis, according to a recent study. This study aimed to assess the impact of access to LDLT in waitlisted patients at highest risk of dropout.
13 Oct 2023
Hypertriglyceridaemia Associated with Severity of Pancreatitis in Non-alcoholic Fatty Liver Disease
Higher triglyceride levels have been linked with incidence of moderately severe and severe acute pancreatitis in non-alcoholic fatty liver disease. The complications of this hypertriglyceridaemia included organ failure and acute peripancreatic fluid collection.
9 Aug 2023
COVID-19 Pandemic Saw Large Increase in Alcohol-related Hepatitis Hospitalisations
A spike in the number of hospitalisations for alcohol-related hepatitis occurred during the COVID-19 pandemic. Read more…
8 Aug 2023
Cirrhosis Mortality Risk: The Impact of Animal Protein Intake
According to new research, higher animal protein intake is associated with greater mortality risk in patients with liver cirrhosis…
7 Jul 2023
Outcomes No Different with Antibiotics in Child–Pugh A Cirrhosis
Stable patients with Child–Pugh A cirrhosis and acute variceal bleeding did not experience different outcomes after antibiotic prophylaxis…
Loading posts...
« Previous
1
…
4
5
6
7
8
…
18
Next »